Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Wrigley Expansion Mirrors Growth Of Confectionary Food Brand

XTALKS VITALS NEWS

Skittles

The new factory space will include a production line for the company’s Skittles product, and will increase the plant’s workforce by 25 percent.

Share this!

June 20, 2016 | by Sarah Massey, M.Sc.

Last week, confectionary company Wrigley, a subsidiary of Mars Incorporated, opened a new addition to its manufacturing facility in Yorkville, Illinois, USA. The 145,000 square foot addition is the result of a $50 million investment by its parent company, Mars.

Tweet: Mars spends $50 million on Yorkville #foodmanufacturing plant http://ctt.ec/4bMod+

The new factory space will include a production line for the company’s Skittles product, and will increase the plant’s workforce by 25 percent. Skittles are now the number one non-chocolate confectionary brand in the US – a fact which was a key driver of the Yorkville expansion.

“Mars has a long-standing history of making our products in the markets where they're sold,” said Casey Keller, President of Wrigley Americas. “With the expansion of our Skittles production footprint, we are proud to continue that tradition right here in the state that Wrigley has called home for 125 years.”

Wrigley attributes the growth of the Skittles brand to “best-in-class marketing, retail activity, innovation and passionate fans.” The newly-renovated Yorkville facility also manufactures other Mars products including Life Savers®, Doublemint® and Juicy Fruit®.



“We are grateful for the support of our state and local communities, which have been instrumental in helping to bring this project to life,” said Keller. “We're fortunate to be able to further invest here in Yorkville, and provide the community with continued economic development.”

Over the past five years, Mars has been expanding rapidly, investing $1 billion in new and improved US manufacturing facilities and creating over 1,000 new jobs. The company plans to invest an additional $900 million in operations expansions and personnel training over the next 2 years.

“Wrigley is an iconic Illinois company, and we are proud it is continuing to grow in our state,” said Illinois Governor Bruce Rauner. “Wrigley has invested nearly $200 million in Illinois over the past seven years, creating hundreds of jobs for Illinois residents. The State of Illinois is glad to be a partner in Wrigley's further expansion.”


Keywords: Food, Food Manufacturing, Food Industry


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
Researchers Identify Role of ApoE4 Gene as Possible Drug Target in Alzheimer’s Disease

September 21, 2017 - A team of neurology researchers at Washington University School of Medicine in St. Louis have found that in the presence of the ApoE4 protein, another protein known as tau forms tangles in the brain which contributes to neuronal damage characteristic of Alzheimer’s disease.

Featured In: Life Science News


New Guidelines Address CAR-T Immunotherapy Toxicities to Prevent Patient Deaths

September 20, 2017 - Clinicians at The University of Texas MD Anderson Cancer Center have published new guidelines in the journal, Nature Reviews Clinical Oncology, which could help in the management of these toxicities.

Featured In: Biotech News, Drug Safety News


Microneedle Skin Patch Could Treat Common Metabolic Disorders

September 19, 2017 - Researchers at Columbia University Medical Center (CUMC) and the University of North Carolina have developed a microneedle skin patch impregnated with a drug capable of converting white fat into calorie-burning brown fat.

Featured In: Medical Device News


LEAVE A COMMENT
 
  
THE XTALKS VITALS INDUSTRY BLOG

Five Reasons Why Toronto is Emerging as a Major Life Sciences Hub

REGISTER FOR THESE WEBINARS

Development and Manufacture of Highly Potent API Drug Products Throughout the Clinical Phases


Innovation through Integration – Providing Next Generation Biomedical Devices and Interconnects


Clinical Payments Case Studies: Improving Efficiency, Cash Management, and Compliance


Why Phase 3 Trials Fail: Oncology Case Studies and Lessons Learned


Copyright © 2016-2017 Honeycomb Worldwide Inc.